Cme Group INC Form 4 insider transactions

Julie Winkler, Sr MD Chief Commercial Officer of CME Group Inc., sold 11,592 shares of Class A common stock on February 13, 2025, at an average price of $249.17.

CME Group director William R. Shepard acquired additional shares of Class A common stock through a dividend reinvestment plan.

CME Group CEO Terrence Duffy sold 11,706 shares of common stock to cover tax obligations related to the vesting of restricted stock.

Director William R. Shepard increased his holdings in CME Group through a dividend reinvestment plan, acquiring additional shares of Class A common stock.

Director Elizabeth A. Cook sold 750 shares of CME Group Inc. on November 12, 2024.

Director Martin J. Gepsman sold 400 shares of CME Group Inc. on November 4, 2024, at a price of $222.92 per share.

Sunil Cutinho, Chief Information Officer of CME Group Inc., sold 4,500 shares of Common Stock Class A at a price of $226.6397 per share on October 30, 2024.

Director Timothy S. Bitsberger of CME Group Inc. reported the sale of 1,000 shares of Common Stock Class A on October 30, 2024.

Timothy Francis McCourt, a Senior Managing Director at CME Group, sold 1,374 shares of Common Stock Class A on October 28, 2024.

Director William R. Shepard reported acquiring CME Group Inc. Class A common stock through a dividend reinvestment plan.

Lynne Fitzpatrick, CFO of CME Group, amends her Form 4 filing to correct a clerical error in the transaction code related to the surrender of shares for tax obligations and the acquisition of shares.

Suzanne Sprague, Sr MD Global Head of Clearing at CME Group, reports the acquisition and disposal of company stock.

Ken Vroman, Chief Transformation Officer of CME Group, reports the acquisition and disposal of company stock related to tax obligations and stock awards.

Sunil Cutinho, Chief Information Officer of CME Group Inc., reports the acquisition and disposal of company stock to cover tax obligations and through new acquisitions.

Lynne Fitzpatrick, CFO of CME Group, reports the acquisition and disposal of company stock, including shares surrendered for tax obligations.

Hilda Harris Piell, Sr MD & Chief HR Officer at CME Group Inc., reports the acquisition and disposal of company stock on September 15 and 16, 2024.

Jonathan L. Marcus, a Senior Managing Director and General Counsel at CME Group Inc., reported the acquisition and disposal of company stock on September 15 and 16, 2024.

Michael G. Dennis, Global Head of Fixed Income at CME Group, reports the acquisition and disposal of CME Group Class A Common Stock.

Timothy McCourt, a Senior Managing Director at CME Group, reported the acquisition and disposal of company stock, including shares surrendered for tax obligations and new shares acquired.

Jack J. Tobin, MD Chief Accounting Officer of CME Group Inc., reports the acquisition and disposal of company stock on September 15 and 16, 2024.

Julie Winkler, Sr MD Chief Commercial Officer of CME Group Inc., reports the acquisition and disposal of company stock related to tax obligations and stock vesting.

Derek Sammann, a Senior Managing Director at CME Group, reported the acquisition and disposal of company stock, including shares surrendered for tax obligations and shares acquired.

Julie Holzrichter, Sr MD Chief Operating Officer of CME Group Inc., reports the acquisition and disposal of company stock.

Terrence A. Duffy, Chairman and CEO of CME Group, recently acquired 27,456 shares of Class A Common Stock at a price of $218.53 per share.

Bryan T. Durkin, a director at CME Group Inc., reported selling 7,593 shares of Common Stock Class A at an average price of $214.59 and gifting 465 shares to a charitable organization.

Director Harold Ford Jr. reports acquiring 748 shares of CME Group Inc. Class A Common Stock at $194.10 per share on June 25, 2024, according to a Form 4 filing.

Director Patrick Maloney reports acquiring 748 shares of CME Group Inc. Class A common stock at $194.10 per share on June 25, 2024.

William Shepard, a director at CME Group Inc., reported acquiring shares of Common Stock Class A through a dividend reinvestment plan and the Director Stock Plan.

Robert J. Tierney Jr., a director at CME Group Inc., acquired 748 shares of Class A Common Stock on June 25, 2024, at a price of $194.1 per share.

Director Daniel Glickman reports acquiring 748 shares of CME Group Inc. at $194.10 per share on June 25, 2024, and holds 14,756 shares directly and 2,100 indirectly through a trust.